Barclays PLC Mesoblast LTD Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.09 $154 - $262	-37 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$5.87 - $7.85 $76,092 - $101,759	-12,963 Reduced 99.72%	37 $0
Q2 2021 Aug 13, 2021	BUY	$6.69 - $9.0 $80,949 - $108,900	12,100 Added 1344.44%	13,000 $97,000
Q1 2021 May 13, 2021	SELL	$8.26 - $11.4 $8,260 - $11,400	-1,000 Reduced 52.63%	900 $7,000
Q4 2020 Feb 11, 2021	SELL	$8.21 - $18.59 $82,100 - $185,900	-10,000 Reduced 84.03%	1,900 $16,000
Q3 2020 Nov 12, 2020	BUY	$11.33 - $19.81 $124,630 - $217,910	11,000 Added 1222.22%	11,900 $221,000
Q2 2020 Aug 12, 2020	BUY	$4.2 - $15.45 $3,780 - $13,905	900 New	900 $10,000
Q1 2019 May 15, 2019	SELL	$4.19 - $5.25 $632 - $792	-151 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.51 - $8.6 $530 - $1,298	151 New	151 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.